Y Imaoka, M Ohira, T Kobayashi… - Journal of Hepato …, 2024 - Wiley Online Library
Background Hepatocellular carcinoma (HCC) ranks third in cancer‐related deaths globally. Despite treatment advances, high post‐hepatectomy recurrence rates (RR), especially with …
Y Imaoka, M Ohira, I Chogahara, T Bekki… - Annals of …, 2023 - Wiley Online Library
Aim The anti‐tumor effects of natural killer (NK) cells vary among individuals. Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) expressed on liver NK cells is a …
X Wang, M Ni, D Han - Evidence‐Based Complementary and …, 2022 - Wiley Online Library
Objective. Biomarkers for pancreatic cancer (PCa) prognosis provide evidence for improving the survival outcome of this disease. This study aimed to identify a prognostic risk model …
Y Imaoka, M Ohira, S Sato, I Chogahara, T Bekki… - JMA journal, 2024 - jstage.jst.go.jp
Introduction: Hepatocellular carcinoma (HCC) is a major global health challenge, being the fifth most prevalent neoplasm and the third leading cause of cancer-related deaths …
C Horozoglu, A Yildiz, D Sonmez, S Demirkol… - Indian Journal of Clinical …, 2024 - Springer
TRAIL, a member of the TNF family, is expressed in tumor and tumor surrounding tissue in many solid organ cancers. While the induction of tumor-specific apoptosis in correlation with …